Associated Papers
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows.
Sobahy TM et al.
Bmc Medical Genomics, 2022
35468810 (PubMed )
Supplement: 12920_2022_1235_MOESM3_ESM.xlsx › OncoKB_unspecified-alterations.
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
Lundgren S et al.
Leukemia, 2021
33785863 (PubMed )
Supplement: 41375_2021_1231_MOESM4_ESM.xlsx › t_som_AA_healthy
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
Kohli M et al.
Ebiomedicine, 2020
32268276 (PubMed )
Supplement: mmc5.xlsx › cfDNA_SNV
Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer.
Tong L et al.
Theranostics, 2019
31534501 (PubMed )
Supplement: thnov09p5532s1.pdf
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 10
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F et al.
Oncotarget, 2016
PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y et al.
Oncology Research, 2016
Comprehensive molecular portraits of human breast tumours.
Unknown Author
Nature, 2012
23000897 (PubMed )
Supplement: NIHMS393293-supplement-4.xls › Sheet_1
Select a paper to view details